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Adenylosuccinate synthetase governs the first commit-
ted step in the de novo synthesis of AMP. Mutations of
conserved residues in the synthetase from Escherichia
coli reveal significant roles for Val273 and Thr300 in the
recognition of L-aspartate, even though these residues do
not or cannot hydrogen bond with the substrate. The mu-
tation of Thr300 to alanine increases the Km for L-aspartate
by 30-fold. In contrast, its mutation to valine causes no
more than a 4-fold increase in the Km for L-aspartate,
while increasing kcat by 3-fold. Mutations of Val
273 to ala-
nine, threonine, or asparagine increase the Km for L-
aspartate from 15- to 40-fold, and concomitantly decrease
the Ki for dicarboxylate analogues of L-aspartate by up to
40-fold. The above perturbations are comparable with
those resulting from the elimination of a hydrogen bond
between the enzyme and substrate: alanine mutations of
Thr128 and Thr129 increase the Km for IMP by up to 30-fold
and the alanine mutation of Thr301 abolishes catalysis
supported by L-aspartate, but has no effect on catalysis
supported by hydroxylamine. Structure-based mecha-
nisms, by which the above residues influence substrate
recognition, are presented.
In a broad range of organisms and cell types, adenylosucci-
nate synthetase (IMP:L-aspartate ligase (GDP-forming); EC
6.3.4.4) plays a significant role in de novo purine nucleotide
biosynthesis, the purine nucleotide cycle, and/or salvage path-
ways for nucleotides (for reviews, see Refs. 1–3). Adenylosuc-
cinate synthetase converts IMP and L-aspartate to adenylosuc-
cinate using GTP as an energy source. The synthetase from
Escherichia coli is a homodimer (4). IMP may play an impor-
tant physiological role in the regulation of synthetase activity
by stabilizing the assembly of inactive monomers into active
dimers (5, 6). As indicated by investigations, first in kinetics
(7–11) and then in x-ray crystallography (12–14), the catalytic
mechanism involves a nucleophilic attack on the -phosphoryl
group of GTP by the 6-oxo group of IMP to form a 6-phosphoryl
intermediate of IMP. The displacement of that 6-phosphoryl
group by the amino group of L-aspartate generates adenylosuc-
cinate. The synthetase recognizes a limited number of sub-
strate alternatives: 2-deoxy-IMP and -D-arabinosyl-IMP sub-
stitute for IMP; 2-deoxy-GTP and GTPS1 for GTP; and DL-
threo--fluoroaspartate, alanine-3-nitronate, cysteine sulfinate,
L-alanosine, and hydroxylamine for L-aspartate (7, 15–17).
Four loops, residues 4053, 120131, 298304, and
416421, undergo conformational transitions in response to
active site ligands (12–14, 18–20). Probably as a consequence of
these ligand-induced changes, the effect of a mutation in the
active site is not easily anticipated from structural information
alone. Asn38, for instance, hydrogen bonds with the 5-phos-
phoryl group of IMP. However, the mutation of Asn38 to alanine
has no effect on the Km for IMP, but reduces kcat by 3 orders of
magnitude (21). His41 hydrogen bonds with GDP (12), but its
mutation to asparagine also increases the Km for L-aspartate by
7-fold (22). The mutation of Arg143, which hydrogen bonds with
the 5-phosphoryl group of IMP, not only elevates the Km for
IMP by 100-fold, but also the Km for GTP by 10-fold (23).
Sequence conservation among adenylosuccinate synthetases
implicate Thr128, Thr129, Val273, Thr300, and Thr301 in impor-
tant functional roles. All of the above residues, except Val273,
belong to flexible loops, which undergo significant conforma-
tional change in response to the binding of IMP (loop 120131)
or L-aspartate (loop 298304). Thr128 and Thr129 interact with
the 5-phosphoryl group of IMP and Thr301 hydrogen bonds
directly to the carboxyl group of hadacidin (N-formyl N-hydrox-
yglycine; an analogue of L-aspartate). The roles of these resi-
dues in substrate recognition can be anticipated on the basis of
their interactions in ligated crystal structures. Reasons for
sequence conservation at positions 273 and 300, however, are
not immediately apparent from crystal structures.
Studies here confirm the anticipated roles of Thr128 and Thr129
in the recognition of IMP and of Thr301 in the recognition of
L-aspartate. Thr300 supports the recognition of L-aspartate most
likely through the influence of its -branched side chain on the
conformation of loop 298304. Most surprising, however, is the
significance of Val273 to the recognition of L-aspartate. Its muta-
tion to alanine, threonine, or asparagine causes 15–40-fold in-
creases in the Km for L-aspartate, while reducing Ki values for
analogues of L-aspartate by up to 40-fold. Evidently, Val273 is
essential in the selection of a catalytically productive conforma-
tion of L-aspartate from an ensemble of four-carbon dicarboxylic
acids, present at appreciable concentrations in vivo.
EXPERIMENTAL PROCEDURES
Materials—Restriction enzymes came from Promega. Pfu DNA po-
lymerase and E. coli strain XL-1 blue were obtained from Stratagene. E.
coli strain H1238 (purA) was a gift from Dr. D. Bachman (Genetic
* This work was supported in part by National Institutes of Health
Research Grant NS10546 and National Science Foundation Grant
MCB-9985565. This is Journal Paper J-19698 of the Iowa Agriculture
and Home Economics Experiment Station, Ames, Project 3191, and
supported by the Hatch Act and State of Iowa Funds. The costs of
publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement”
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ Present address: Dept. of Biochemistry and Molecular Biology,
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§ Present address: Structural Chemistry Dept., Schering-Plough Re-
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¶ Present address: Biochemistry Dept., University of Wisconsin,
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1 The abbreviation used is: GTPS, guanosine 5-3-O-(thio)triphos-
phate.
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Center, Yale University, New Haven, CT). Phenyl-Sepharose CL-4B
came from Amersham Biosciences, Inc., and hydroxylamine hydrochlo-
ride from Fisher Scientific. Other reagents and chemicals came from
Sigma, unless specified otherwise.
Expression of Wild-type and Mutant Enzymes—Details regarding the
construction of pTrpA are in the literature (21). The purA gene in
PMS204 was amplified using PCR and Pfu DNA polymerase, and sub-
cloned into pTrc99A (Amersham Biosciences, Inc.). The resulting plas-
mid (pTrpA) was transformed into E. coli strain H1238, which cannot
express the endogenous synthetase (purA).
Directed Mutations—The NcoI-PstI fragment containing purA was
subcloned into pAlterEXII (Promega). Directed mutagenesis followed
the protocol provided by Promega, Inc., using the following primers:
5-AGCGATCGGCGCCACCGGTCG-3 for Thr128 3 Ala, 5-CGATCG-
GCACCGCCGGTCGTGGT-3 for Thr129 3 Ala, 5-ACTCCACTCGTG-
CAGGTGCAGGTC-3 for Val273 3 Ala, 5-ACTCCACTCGTACAGGT-
GCAGGTC-3 for Val273 3 Thr, 5-ACTCCACTCGTAATGGTGCAGG-
TC-3 for Val273 3 Asn, 5-GAATTCGGCGCAGCTACGGGGCG-3 for
Thr3003 Ala, and 5-TTCGGCGCAACTGCGGGGCGTCG-3 for Thr301
3 Ala.
Nucleotide residues underlined above are mismatched with respect
to the wild-type sequence. The sequencing primer used to confirm
mutations at positions 128 and 129 was 5-TCTGAAGCATGTCCGCT-
GATC-3, and that used for mutations at positions 273, 300, and 301
was 5-CTGCTGGATATCGACCACGG-3. Oligonucleotide synthesis
and DNA sequencing (dideoxy dye termination protocol) were done by
the Nucleic Acid Facility of Iowa State University. The NcoI-PstI frag-
ment with the desired mutation was subcloned into pTrc99A and trans-
formed into E. coli, purA strain H1238 for expression.
Preparation of Wild-type and Mutant Enzymes—Wild-type and mu-
tant enzymes were purified as described elsewhere (21–24) with the
following modifications: The phenyl-Sepharose CL-4B column was
washed in succession with solutions of 0.6, 0.4, and 0.2 M ammonium
sulfate, buffered by 50 mM potassium phosphate, pH 7.0. Wild-type and
mutant synthetases eluted from the column in 0.2 M ammonium sulfate.
Appropriate fractions were pooled, concentrated, and dialyzed against
50 mM potassium phosphate, pH 7.0, then further purified by DEAE-
TSK high performance liquid chromatography (Toso-Haas). Enzyme
purity was monitored by SDS-polyacrylamide electrophoresis (25), and
concentrations were determined by the method of Bradford (26), using
the reagent from Bio-Rad. Circular dichroism spectra for mutant and
wild-type synthetases were taken as described elsewhere (21–23).
Kinetic Assays with L-Aspartate—The ultraviolet difference spectrum
of a reaction solution, containing 20 mM Hepes, pH 7.7, 1 mM GTP, 450
M IMP, 6 mM magnesium chloride, 5 mM L-aspartate, and 20 g/ml
wild-type enzyme was recorded at 25 °C on a GBC UV-visible 918
spectrophotometer, equipped with a Peltier-Effert temperature control-
ler. Kinetic parameters of wild-type and mutant enzymes were deter-
mined at 25 °C by monitoring absorbance changes at 290 nm, where the
extinction coefficient for the conversion of 1 mol of IMP into adenylo-
succinate is 3.51  106 cm2/mol. Assay solutions contained 20 mM
Hepes, pH 7.7, 5 mM magnesium chloride, and fixed concentrations for
two of the three substrates, as appropriate, in the determination of Km
for the remaining substrate (11). Fixed concentrations of GTP, IMP,
and L-aspartate were 0.30, 0.50, and 5.0 mM, respectively, unless spec-
ified otherwise in tables of kinetic parameters, presented below. 1200
g/ml wild-type or mutant enzyme was used in each assay, depending
upon its specific activity. Determination of kcat and Km values employed
the program ENZFITTER (27).
Kinetic Assays with Hydroxylamine (NH2OH)—3 M hydroxylamine
was freshly made from hydroxylamine hydrochloride and adjusted to
pH 7.7 by the addition of potassium hydroxide. The ultraviolet differ-
ence spectrum of a reaction solution containing 20 mM Hepes, pH 7.7, 1
mM GTP, 450 M IMP, 6 mM magnesium chloride, 400 mM hydroxyla-
mine, and 20 g/ml wild-type enzyme, was recorded at 25 °C on a GBC
UV-visible 918 spectrophotometer, equipped with a Peltier-Effert tem-
perature controller. Kinetic assays were conducted as above at pH 7.7,
using fixed concentrations of GTP, IMP, and hydroxylamine of 1, 0.5,
and 400 mM, respectively, and 2-mm quartz cuvettes, to offset the
strong absorbance of GTP at 280 nm. Determinations of the Hill coef-
ficient for Mg2 came from assays that employed 25 g/ml wild-type
enzyme, 100 mM hydroxylamine, 450 M IMP, 250 M GTP, and mag-
nesium chloride from 50 M to 7 mM. At 280 nm the extinction coeffi-
cient for the conversion of 1 mol of IMP into 6-N-hydroxy-AMP is 11.7 
106 cm2/mol. Determination of kcat, Km, and the Hill coefficient for Mg
2
employed the program ENZFITTER (27).
Determination of Ki for Inhibitors—The inhibition constants for suc-
cinate, fumarate, and maleate were determined from a 5  5 matrix of
conditions, which systematically varied L-aspartate and inhibitor con-
centrations. Assays contained 20 mM Hepes, pH 7.7, 5 mM magnesium
chloride, 500 M IMP, and 300 M GTP. Enzyme concentrations were 4,
30, 20, and 66 g/ml for the wild-type, Val2733 Ala, Val2733 Asn, and
Val2733 Thr enzymes, respectively. L-Aspartate varied from one half to
5 times its Km (depending upon the mutant examined), and inhibitor
concentrations varied from 0 to 15 mM succinate, from 0 to 16.7 mM
fumarate, or from 0 to 10 mM maleic acid. Kinetic parameters for
inhibition were determined by linear regression, using the MINITAB
program and a value for  of 2.0 (28).
Sequence Comparisons—The Biology WorkBench of the San Diego
Supercomputing Center (workbench.sdsc.edu) served as a platform in
sequence similarity searches (29) and multiple sequence alignments
(30). Sequences of adenylosuccinate synthetases were identified ini-
tially by their match to the 9-residue P-loop of the synthetase (single-
letter amino acid sequence: QWGDEGKGK).
RESULTS
Conservation of Target Residues—Positions 129 and 273 are
threonine and valine, respectively, in all sequences of adenylo-
succinate synthetases extracted from the Protein Information
Resource data base (a total of 45 entries), whereas positions
128 and 301 are threonine in 44 sequences (serine was the
alternative residue). In 32 of 45 sequences, position 300 is
threonine, the alternative residue types being valine (10 in-
stances), serine (2 instances), and asparagine (1 instance). Se-
quences within the adenylosuccinate synthetase family exhibit
at least 40% identity for any pairwise alignment.
Purity and Secondary Structure of Mutant Enzymes—The
mutant and wild-type enzymes migrate comparably on phenyl-
Sepharose and DEAE columns. All proteins were at least 95%
pure on the basis of SDS-polyacrylamide gel electrophoresis.
Circular dichroism spectra of all enzymes were identical from
TABLE I
Kinetic parameters for wild-type and mutant adenylosuccinate synthetases
See text for conditions of assay. Km
GTP, Km
IMP, and Km
Asp are the Michaelis constants for GTP, IMP, and L-aspartate, respectively.
Enzymea kcat Km
GTP Km
IMP Km
Asp kcat/Km
GTP kcat/Km
IMP kcat/Km
Asp
s1 M M mM s1 mM1 s1 mM1 s1 mM1
Wild-type 1.00  0.05 26  2 28  1 0.23  0.04 38  4 36  3 4.4  0.8
Thr128 3 Alab 0.46  0.03 54  6 310  50 0.17  0.02 9  1 1.5  0.3 2.7  0.4
Thr129 3 Alac 0.42  0.01 1700  60 890  70 0.24  0.01 0.25  0.01 0.47  0.04 1.75  0.08
Thr300 3 Alad 0.64  0.04 170  10 19  1 6.2  0.7 3.9  0.4 34  3 0.10  0.01
Thr300 3 Val 3.3  0.2 56  6 33  3 0.82  0.02 60  7 100  10 4.1  0.2
Val273 3 Alad,e 1.00  0.1 31  3 17  2 7  1 32  5 59  9 0.14  0.03
Val273 3 Asnd,e 0.050  0.001 21  2 24  2 9  2 2.4  0.2 2.1  0.2 0.006  0.001
Val273 3 Thrd,e 1.99  0.02 45  7 43  4 3.4  0.2 44  1 46  6 0.61  0.07
a Observed no catalytic activity for the Thr301 3 Ala enzyme under conditions specified in the text.
b Employed fixed concentrations of 0.25 mM IMP and 0.45 mM GTP.
c Employed fixed concentrations of 6 mM IMP and 0.60 mM GTP.
d Employed fixed concentration of 25 mM L-aspartate.
e Assayed with 25 mM magnesium chloride while varying the concentration of L-aspartate.
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200 to 260 nm (data not shown), indicating no major changes in
secondary structure.
Kinetics with L-Aspartate—Km
Asp and kcat values for the wild-
type, Thr1283 Ala, and Thr1293 Ala enzymes are comparable
(Table I). In contrast, the mutation of Thr128 to alanine in-
creases Km
IMP and Km
GTP by 10- and 2-fold, respectively, and the
mutation of Thr129 to alanine increases Km
IMP and Km
GTP by 30-
and 80-fold, respectively. Mutations of position 273 have little
effect on Km
GTP and Km
IMP, but increase Km
Asp by 30-, 40-, and
15-fold for the alanine, asparagine, and threonine mutations,
respectively. Values of kcat for the Val
273 3 Ala and Val273 3
Thr enzymes are similar (2-fold less and 3-fold greater than,
respectively) to that of the wild-type enzyme, but the mutation
of Val273 to asparagine causes a 20-fold reduction in kcat. The
mutation of Thr300 to alanine elevates Km
GTP by 5-fold and Km
Asp
by 30-fold. In contrast, Km
GTP and Km
IMP increase by 2-fold or less
as a result of the mutation of Thr300 to valine, and kcat and Km
Asp
increase by only 3-fold. The mutation of Thr301 to alanine
results in the complete loss of activity under conditions em-
ployed here (20 mM Hepes, pH 7.7, 1 mM GTP, 500 M IMP, 6
mM Mg2, 25 mM L-aspartate, 200 g/ml protein).
Kinetic parameters for the inhibition of wild-type enzyme and
position 273 mutant synthetases by succinate, fumarate, and
maleate vary over a broad range of affinities (Table II). All kinetic
mechanisms of inhibition are competitive with respect to L-
aspartate, fitting to Equation 1 with a goodness-of-fit below 5%.
1/V 1/Vmax  1Ka/AKia  I/Ki  A (Eq. 1)
In Equation 1, v is the initial velocity, Vmax is the maximal
velocity, A is the concentration of L-aspartate, I is the inhibitor
concentration, Ka is the Michaelis constant for L-aspartate, Ki
is the dissociation constant for the inhibitor, and Kia is the
dissociation constant for L-aspartate. All of the position 273
mutants exhibit significant decreases in Ki relative to the wild-
type enzyme for at least one of the alternative dicarboxylic
acids (Table II). Each of the dicarboxylic acids, however, were
more effective inhibitors (by up to 40-fold) of the Val273 3 Thr
enzyme relative to the wild-type synthetase.
Kinetics with Hydroxylamine—Ala301, Ala273, Thr273, Asn273,
and wild-type enzymes exhibit similar kinetic parameters
when assayed with hydroxylamine (Table III). Km
hydroxylamine,
Km
GTP, and Km
IMP vary over a 3-fold range, whereas kcat varies
6-fold among the enzymes of Table III. The Hill coefficient for
Mg2, however, falls from 2 to unity when hydroxylamine
replaces L-aspartate (data not shown).
DISCUSSION
The residues studied here cluster in the vicinity of the L-
aspartate and IMP binding sites (Fig. 1). The side chain of
Thr128 hydrogen bonds with Asp114, facilitating hydrogen
bonds between the side chain and backbone amide of Thr129
with the 5-phosphoryl group of IMP. The side chain of Thr300
approaches and may hydrogen bond weakly with backbone
carbonyl 38 and the side chain of His53. The backbone amide
FIG. 1. Relative positions of residues subject to mutation. Top,
location of residues relative to a single subunit of the adenylosuccinate
synthetase dimer; bottom, a more detailed view showing specific inter-
actions. Donor-acceptor interactions and selected nonbonded contacts
are indicated by dashed lines. Coordinates are from the
GDPIMPNO3
Mg2hadacidin complex (Ref. 37; Protein Data Base
accession code 1cib). This drawing was done with MOLSCRIPT (38).
TABLE II
Inhibition constants for wild-type and position 273 mutant enzymes
See text for details regarding conditions of assay. Ki for various
inhibitors is defined by Equation 1 in the text.
Enzyme
Ki
Succinate Fumarate Maleate
M M M
Wild-type 890  50 NIa 3100  80
Val273 3 Ala NIa 180  40 1000  200
Val273 3 Asn NIa 40  10 210  8
Val273 3 Thr 80  10 640  80 78  5
a Noninhibitory to a concentration of 10 mM.
TABLE III
Kinetic parameters of wild-type and mutant synthetases with
hydroxylamine
See text for details regarding the conditions of assay.
Enzyme kcat Kmhydroxylamine KmGTP KmIMP
s1 mM M M
Wild-type 0.50  0.09 230  80 190  20 66  7
Thr301 3 Ala 0.24  0.04 91  3 57  7 320  90
Val273 3 Ala 0.21  0.02 255  60 140  40 140  20
Val273 3 Asn 0.29  0.08 110  70 180  30 113  7
Val273 3 Thr 0.080  0.002 140  30 74  8 77  6
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and side chain of Thr301 hydrogen bond with the carboxyl group
of hadacidin (an analogue of L-aspartate). The conformation of
bound hadacidin in crystallographic complexes is consistent
with an intramolecular hydrogen bond between the -carboxyl
and -amino groups of L-aspartate (3, 12). The -carboxyl group
may then abstract a proton from the -amino group of L-aspar-
tate in catalyzing the second step of the synthetase reaction.
The side chain of Val273 makes nonbonded contacts with ha-
dacidin and with the aliphatic methylene carbons of the side
chain of Arg305. Although side chains larger than an isopropyl
group at position 273 could come into steric conflict with L-
aspartate, there are no steric conflicts in the substitution of
side chains of smaller or similar size. The backbone carbonyl of
Val273 hydrogen bonds with the 2-hydroxyl group of IMP, but
this interaction may not be important as 2-deoxy-IMP is a good
substrate for the synthetase (31). The side-chain conformation
of Val273 is unfavorable (1  240°, an eclipsed conformation;
Fig. 2). Efforts to build and refine (by simulated annealing), the
side chain in a staggered conformation (1  60°, 180°, or 300°)
return the unfavorable torsion angle.2 Staggered conforma-
tions for Val273 cause unacceptable contacts with backbone
carbonyl 273 and/or the CG atom of Arg305.
Thr128 3 Ala and Thr129 3 Ala synthetases exhibit 10- and
30-fold increases in Km
IMP, respectively, while retaining wild-
type levels of activity. Presumably, the hydrogen bond between
Thr128 and Asp114 stabilizes the ligand-bound conformation of
loop 120131, and facilitates interactions between Thr129 and
the 5-phosphoryl group of IMP. Evidently, interactions involv-
ing Thr128 and Thr129 do little to stabilize the transition state
(kcat falls only 2-fold because of these mutations). In this re-
gard, the effects of mutations at positions 128 and 129 and at
Arg143 are similar. The side chain of Arg143 from a symmetry-
related monomer of the synthetase dimer hydrogen bonds with
the 5-phosphoryl group of IMP. The mutation of Arg143 to
leucine or lysine results in a 100-fold increase in Km
IMP and no
change in kcat (6). In contrast, the mutation of Asn
38, which also
hydrogen bonds with the 5-phosphoryl group of IMP, has no
effect on Km
IMP, but causes a 1000-fold decrease in kcat (21).
The 60-fold increase in Km
GTP relative to the wild-type enzyme
for the Thr129 3 Ala mutant must come from an indirect
mechanism, as Thr129 and GTP are separated by more than 10
Å. A 10-fold increase in Km
GTP was observed for the Arg143 3
Leu synthetase (6). Correlated changes in Km
IMP and Km
GTP prob-
ably stem from binding synergism between IMP and GTP,
which may originate from the interaction of Asn38 with the
5-phosphoryl group of IMP. In a crystal structure of an IMP-
synthetase complex (32), loop 4053 adopts the conformation
of the GDP-bound synthetase in the absence of guanine nucle-
otide. IMP alone, through its interaction with Asn38, can sta-
bilize the GDP-bound conformation of loop 4053. Correlated
changes in Km
IMP and Km
GTP because of mutations at positions
129 and 143, then, may stem from a perturbation of the Asn38-
IMP interaction and a concomitant loss in the ability of IMP to
drive conformational changes in loop 40–53.
The significant effects on Km
Asp and/or kcat resulting from
mutations of threonines 300 and 301 to alanine are in harmony
with those observed in mutations of Arg303, and Arg304 and
Arg305 to leucine (33). Crystallographic structures implicate
loop 298304 in the recognition of the -carboxyl group of
L-aspartate (3, 12). The 30-fold increase in Km
Asp for the Thr300
3 Ala synthetase may arise in part from the loss of weak
hydrogen bonds involving the side chain of Thr300, but other
factors are involved here as well. The -branched side chain at
position 300 limits allowable main-chain torsion angles relative
to the methyl group of alanine. The Thr3003 Val enzyme retains
the conformational restraints because of the -branched side
chain, but eliminates side-chain hydrogen bonds. The conse-
quence is only a 3-fold increase in Km
Asp and an increase in kcat of
300%. The modest effects of the Thr300 3 Val mutation are
consistent with the presence of valine at position 300 in 25% of
known sequences for the synthetase. The 5-fold increase in Km
GTP
resulting from the mutation of Thr300 to alanine may reflect
binding synergism between L-aspartate and GTP. GTP/L-aspar-
tate binding synergism may stem in part from the coordination of
each ligand to a common Mg2. In addition, a series of crystal
structures (14) demonstrate enhanced interactions between
Arg305 (which putatively binds to the -carboxyl group of L-
aspartate) and the -phosphoryl group of the guanine nucleo-
tide in the presence of hadacidin (the L-aspartate analogue).
As the Thr301 3 Ala synthetase is inactive in assays using
L-aspartate, we are unable to determine whether the loss of
activity is the result of an effect on kcat or to a large increase in
Km
Asp. If the mutation of Thr301 to alanine eliminates critical
hydrogen bonds with the -carboxyl group of L-aspartate, as
inferred by crystal structures and model building (3, 12), then the
Thr301 3 Ala mutant enzyme and the wild-type enzyme should
respond comparably to hydroxylamine as an alternative sub-
strate. Indeed, kinetic parameters for the Thr301 3 Ala mutant
are similar to those of the wild-type enzyme when hydroxylamine
is used in place of L-aspartate (Table III). The apparent satura-
tion effect, observed with increasing concentrations of hydroxyl-
amine, may be a consequence then of reduced specific activity of
the synthetase at high ionic strength. So, in fact, the reaction
involving hydroxylamine may be diffusion-controlled.
The reduced Hill coefficients in reactions that employ hy-
droxylamine reaffirm the correlated binding of L-aspartate and2 Z. Hou and R. B. Honzatko, unpublished results.
FIG. 2. Interactions of amino acid
residue 273. Val273 makes allowable
nonbonded contacts with Arg305 at the
cost of an unfavorable 1 torsion angle in
the GDPIMPNO3
Mg2hadacidin com-
plex (Protein Data Base accession code
1cib; left). Thr273 makes allowable non-
bonded contacts with Arg303 and Arg305,
while adopting a favorable 1 torsion an-
gle in the GDPIMPMg2succinate com-
plex, but Arg303 may not hydrogen bond
with the carboxyl group of succinate
(right). Donor-acceptor interactions and
selected nonbonded contacts are indicated
by dashed lines. This drawing was done
with MOLSCRIPT (38).
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a second Mg2 in the kinetic mechanism of the synthetase (34).
Evidently, only one Mg2 participates in the hydroxylamine
reaction, whereas two are involved in the L-aspartate reaction.
Kang and Fromm (34) suggest that a second Mg2 binds to the
carboxyl groups of L-aspartate, to reduce the pKa of its -amino
group. An alternative model puts the second Mg2 between the
-carboxyl group of L-aspartate and the side chain of Asp13, to
offset the effects of an unacceptable nonbonded contact be-
tween these groups (3). Both models are consistent with the
reduced Hill coefficient observed in the presence of hydroxyla-
mine. Mg2 may not coordinate hydroxylamine effectively, but
its pKa (8.0) is low enough to support catalysis at pH 7.7 (pH of
optimal activity) without the influence of a second Mg2.
Although only nonbonded contacts are evident in crystal
structures between Val273 and hadacidin, the mutation of
Val273 to alanine causes a 30-fold increase in Km
Asp. As the
mutation puts a small side chain in place of a larger one,
unfavorable steric interactions with the substrate are unlikely.
Furthermore, the productive binding of L-aspartate to the
Ala273 mutant and wild-type enzymes must be nearly identical,
as Km
GTP (which reflects L-aspartate/GTP-binding synergism)
and kcat are unchanged. Mutation to a larger side chain (Val
273
3 Asn) causes a 40-fold increase in Km
Asp and a 20-fold reduc-
tion in kcat, suggesting a perturbation in the productive binding
of L-aspartate, resulting perhaps from the steric effects from a
side chain with increased size. The isosteric mutation Val2733
Thr, however, still causes a 15-fold increase in Km
Asp, whereas
kcat actually increases 200%.
Inhibition of position 273 mutants by dicarboxylic acids pro-
vides a measure of insight as to how Val273 functions in sub-
strate recognition. Fumarate is a potent inhibitor of the Ala273
and Asn273 mutant enzymes, but has no effect on the wild-type
enzyme, and similarly succinate and maleate become potent
inhibitors of the Thr273 mutant enzyme. The active sites of
position 273 enzymes generally recognize a more diverse set of
dicarboxylic acids than does the wild-type active site. This
broadened recognition for dicarboxylic acids may allow L-aspar-
tate to bind in different modes to the active sites of the position
273 mutants. Productive binding for L-aspartate is retained in
the Thr273 and Ala273 mutant enzymes, but other, nonproduc-
tive binding modes may be important. These nonproductive
binding modes may include, for instance, the ligation of the
-carboxyl group of L-aspartate to the active site Mg2 (back-
ward binding) and/or the binding of L-aspartate in a conforma-
tion that does not permit the formation of an intramolecular
hydrogen bond between its -carboxyl and -amino groups.
Hence, the Km
Asp may increase for position 273 mutants en-
zymes because of competition between productive and nonpro-
ductive binding modes of the substrate.
The kinetic properties of the above mutations are clearly
consistent with the absolute sequence conservation of valine at
position 273. In fact, the selective pressures that retain posi-
tion 273 as valine are now evident. In vivo concentrations of
fumarate, succinate, and L-aspartate in E. coli are 0.4, 0.4,
and 2 mM (35, 36). The mutations at position 273, presented
here, are relatively conservative, yet each generates an enzyme
that has a Km
Asp at least 5-fold higher than intracellular con-
centrations of L-aspartate and vastly improved binding affini-
ties for succinate and fumarate. Under physiological condi-
tions, then, the position 273 mutant enzymes are inactive.
In preliminary crystal structures of the Thr273 synthetase in
complexes with succinateIMPGDPMg2 and maleateIMP
GDPMg2 at 2-Å resolution,3 the active site is not substan-
tially altered by the mutation. Succinate and maleate coordi-
nate to Mg2 and hydrogen bond to loop 298304, as observed
in the hadacidin-ligated active site of the wild-type enzyme.
Thr273 has a 1 angle of 300°, a rotation of 60° relative to the 1
angle for the side chain of Val273 of the wild-type enzyme (Fig.
2). The side chain of Thr273 now makes nonbonded contacts
with both Arg303 and Arg305, but no hydrogen bonds. Arg303
approaches, but may not hydrogen bond with, succinate. These
subtle differences in conformation may be caused by the mu-
tation at position 273 or to the replacement of hadacidin with
succinate/maleate. Information from the hadacidin complex of
the Thr273 enzyme is necessary before definitive conclusions
are possible. Nonetheless, the functional consequences of the
mutation of Val273 to threonine are not the result of gross
conformational changes at the active site and/or hydrogen
bonding of the threonine hydroxyl group OG1.
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